3 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 3 |
Follow Elritercept: new trials by email Literature Review of Elritercept trials Research Report on Elritercept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib Placebo, Elritercept - Myelofibrosis, Anemia | Phase 3 | Recruiting | Takeda | 324 | 2026-09-10 | 2026-10-01 |
| A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions Elritercept, Epoetin Alfa - Myelodysplastic Syndrome, Anemia | Phase 3 | Recruiting | Takeda | 300 | 2026-05-21 | 2026-10-19 |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions Elritercept, Placebo - Myelodysplastic Syndromes | Phase 3 | Recruiting | Takeda | 225 | 2025-05-06 | 2026-10-23 |
Anemia (3) · Myelodysplastic Syndromes (2) · Primary Myelofibrosis (1)
Takeda (3)
Australia (3) · Brazil (3) · Bulgaria (3) · France (3) · Germany (3) · Hungary (3) · India (3) · Ireland (3) · Italy (3) · Poland (3) · South Korea (3) · Spain (3) · Taiwan (3) · Turkey (Türkiye) (3) · United Kingdom (3)
2025 (1)